The weekly combination therapy is intended for adults with poor glucose control despite basal insulin or GLP-1 receptor ...

After launching a multi-campus phased rollout of the predictive insulin dosing software, Philadelphia-based Temple Health’s University Hospital has reduced hypoglycemia rates two- to threefold.   The ...

Dallara, president of Medtronic’s diabetes business, discussed the segment’s turnaround and why she sees a benefit in ...

A Channel 4 documentary has examined whether the nurse's convictions are a result of justice or the total opposite.

SaveHealth reports insulin has revolutionized diabetes care since its discovery, with various types enhancing patient management and flexibility.

ViCentra's Kaleido is "the smallest, thinnest, lightest, most precise insulin patch pump in its class," CEO Tom Arnold said ...

VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...

Murder or Mistake, examines the evidence provided by the prosecution - discussing whether she really is a killer nurse or the subject of a horrific miscarriage of justice ...

If approved, Awiqli would become the first once-weekly basal insulin available in the United States for adults with Type 2 ...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that its t:slim X2™ insulin pump with Control-IQ+ automated insulin delivery (AID ...

French drugmaker Sanofi said on Friday it would offer a month's supply of any of its insulin products for $35 to all patients ...

This month most of the startups that caught our attention include a one making a more environmentally friendly fertilizer, a ...